Cross‐sectional HIV incidence estimation in an evolving epidemic

The cross-sectional approach to HIV incidence estimation overcomes some of the challenges with longitudinal cohort studies and has been successfully applied in many settings around the world. However, the cross-sectional approach does rely on an initial training data set to develop and calibrate the statistical methods to be used in cross-sectional surveys. The problem addressed in this paper is that the initial training data set may, over time, not reflect the current target population of interest because of evolution of the epidemic. For example, the mismatch between the target population and the initial data set could occur because of increasing use of anti-retroviral therapy among HIV-infected persons throughout the world. We developed methods to adjust the initial training data set with the goal that the adjusted data sets better reflect the target population. These adjustment procedures could help avoid the time and expense of collecting a completely new training data set from the current target population. We report the results of a simulation study to evaluate the procedures. We applied the methods to a dataset of HIV subtype B infection. The adjustment procedures could be applicable in situations other than cross-sectional incidence estimation where complex statistical analyses are to be conducted using an initial data set but those results may not be directly transportable to a new target population of interest. The approach we have proposed could offer a practical and cost-effective way to apply cross-sectional incidence methods to new target populations as the epidemic evolves.

[1]  R. Brookmeyer Accounting for Follow‐up Bias in Estimation of Human Immunodeficiency Virus Incidence Rates , 1997 .

[2]  Oliver Laeyendecker,et al.  Estimation of HIV incidence using multiple biomarkers. , 2013, American journal of epidemiology.

[3]  D. Horvitz,et al.  A Generalization of Sampling Without Replacement from a Finite Universe , 1952 .

[4]  M. Hernán Beyond exchangeability: The other conditions for causal inference in medical research , 2012, Statistical methods in medical research.

[5]  R. Brookmeyer On the Statistical Accuracy of Biomarker Assays for HIV Incidence , 2010, Journal of acquired immune deficiency syndromes.

[6]  C. Morrison,et al.  Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. , 2015, AIDS research and human retroviruses.

[7]  P. Ghys,et al.  Global trends in molecular epidemiology of HIV-1 during 2000–2007 , 2011, AIDS.

[8]  R. Brookmeyer,et al.  Identification and validation of a multi‐assay algorithm for cross‐sectional HIV incidence estimation in populations with subtype C infection , 2018, Journal of the International AIDS Society.

[9]  R Brookmeyer,et al.  Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. , 1995, American journal of epidemiology.

[10]  Barbara Suligoi,et al.  Estimating the distribution of the window period for recent HIV infections: A comparison of statistical methods , 2010, Statistics in medicine.

[11]  T. Quinn,et al.  Response to the AIDS pandemic--a global health model. , 2013, The New England journal of medicine.

[12]  Robert Tibshirani,et al.  Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .

[13]  N. McGrath,et al.  Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. , 2014, The Lancet. Global health.

[14]  O. Laeyendecker,et al.  Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. , 2015, The Journal of infectious diseases.

[15]  Oliver Laeyendecker,et al.  Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study. , 2016, The lancet. HIV.

[16]  Alex Welte,et al.  Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. , 2010, AIDS.

[17]  Connie Celum,et al.  HIV incidence determination in the United States: a multiassay approach. , 2013, The Journal of infectious diseases.

[18]  Reshma Kassanjee,et al.  Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository , 2014, AIDS.

[19]  Edward H. Kaplan,et al.  Snapshot Estimators of Recent HIV Incidence Rates , 1999, Oper. Res..

[20]  Richard D Moore,et al.  Performance of a Limiting-Antigen Avidity Enzyme Immunoassay for Cross-Sectional Estimation of HIV Incidence in the United States , 2013, PloS one.

[21]  J M Robins,et al.  Identifiability, exchangeability, and epidemiological confounding. , 1986, International journal of epidemiology.

[22]  S. Lagakos,et al.  Challenges to HIV prevention--seeking effective measures in the absence of a vaccine. , 2008, The New England journal of medicine.

[23]  Stephen R Cole,et al.  The consistency statement in causal inference: a definition or an assumption? , 2009, Epidemiology.

[24]  S. Cole,et al.  Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data. , 2006, American journal of epidemiology.

[25]  Till Bärnighausen,et al.  Errors in ‘BED’-Derived Estimates of HIV Incidence Will Vary by Place, Time and Age , 2009, PloS one.